Literature DB >> 14755321

Mobilized blood cells vs bone marrow harvest: experience compared in 171 donors with particular reference to pain and fatigue.

L Karlsson1, D Quinlan, D Guo, C Brown, S Selinger, J Klassen, J A Russell.   

Abstract

This prospective study compared the donor experience of blood cell (BC) mobilization and leukapheresis (n=116) with that of bone marrow (BM) harvest (n=55). Internal jugular catheters were inserted electively in 89% of BC donors. Most (80%) BM donors had a harvest with general anesthesia; 20% had epidural or spinal anesthesia. Pain and fatigue were frequent with both procedures and were compared in responses to questionnaires. A total of 85% of BM donors reported moderate or severe pain compared with 68% of BC donors (P=0.02). The median duration of pain was 14 days for BM donors compared with 3 days after BC mobilization (P<0.0001). More BM donors had pain for more than 7 days (75% vs 0%, P<0.0001). Severe fatigue was experienced by more BM donors (49 vs 16%, P<0.0001). Fatigue lasted significantly longer in BM donors (median 11 vs 4 days, P<0.0001) and more BM donors were fatigued for more than 1 week (69 vs 0%, P<0.0001). A total of 11 donors had both BM and BC collection; seven preferred the latter. Simply considered with respect to pain and fatigue, BC donation appears better tolerated by donors. However, there are other sequelae of both influencing the acceptability for individual donors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755321     DOI: 10.1038/sj.bmt.1704418

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

Review 1.  A review of the haematopoietic stem cell donation experience: is there room for improvement?

Authors:  A Billen; J A Madrigal; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-01-27       Impact factor: 5.483

2.  Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.

Authors:  Linda J Burns; Brent R Logan; Pintip Chitphakdithai; John P Miller; Rebecca Drexler; Stephen Spellman; Galen E Switzer; John R Wingard; Claudio Anasetti; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-21       Impact factor: 5.742

3.  The role of donor characteristics and post-granulocyte colony-stimulating factor white blood cell counts in predicting the adverse events and yields of stem cell mobilization.

Authors:  Shu-Huey Chen; Shang-Hsien Yang; Sung-Chao Chu; Yu-Chieh Su; Chu-Yu Chang; Ya-Wen Chiu; Ruey-Ho Kao; Dian-Kun Li; Kuo-Liang Yang; Tso-Fu Wang
Journal:  Int J Hematol       Date:  2011-04-21       Impact factor: 2.490

Review 4.  Hematopoietic stem cell donation.

Authors:  Shu-Huey Chen; Tso-Fu Wang; Kuo-Liang Yang
Journal:  Int J Hematol       Date:  2013-02-19       Impact factor: 2.490

5.  Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?

Authors:  Courtney D Fitzhugh; Matthew M Hsieh; Charles D Bolan; Carla Saenz; John F Tisdale
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

6.  Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201.

Authors:  Galen E Switzer; Jessica G Bruce; Donna Harrington; Michael Haagenson; Rebecca Drexler; Amy Foley; Dennis Confer; Michelle Bishop; Paolo Anderlini; Scott Rowley; Susan F Leitman; Claudio Anasetti; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2013-11-01       Impact factor: 5.742

7.  Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; John P Miller; Brent R Logan; Roberta J King; J Douglas Rizzo; Susan F Leitman; Paolo Anderlini; Michael D Haagenson; Seira Kurian; John P Klein; Mary M Horowitz; Dennis L Confer
Journal:  Blood       Date:  2009-02-03       Impact factor: 22.113

Review 8.  Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments.

Authors:  Mateja Kralj Juric; Sakhila Ghimire; Justyna Ogonek; Eva M Weissinger; Ernst Holler; Jon J van Rood; Machteld Oudshoorn; Anne Dickinson; Hildegard T Greinix
Journal:  Front Immunol       Date:  2016-11-09       Impact factor: 7.561

9.  Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.

Authors:  Nicole C McCoy; Ellen L Hay; Deborah A Romeo; J Wesley Doty; Bethany J Wolf; Michelle P Hudspeth
Journal:  Front Med (Lausanne)       Date:  2022-04-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.